Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Girolamo Ranieri

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Current Medicinal Chemistry|January 5, 2012
Hot topic: targeting tumor angiogenesis: an updateGirolamo Ranieri
International Journal of Molecular Sciences|June 6, 2018
Biological Basis of Tumor Angiogenesis and Therapeutic Intervention: Past, Present, and FutureGirolamo Ranieri
Experimental Cell Research|December 6, 2014
Tryptase, a novel angiogenic factor stored in mast cell granulesDomenico Ribatti, Girolamo Ranieri
Cancers|September 29, 2020
Loco-Regional and Systemic Chemotherapies for Hepato-Pancreatic Tumors: Integrated TreatmentsGirolamo Ranieri, Carmelo Laface
Critical Reviews in Oncology/Hematology|November 12, 2010
Trans-arterial chemoembolization as a therapy for liver tumours: New clinical developments and suggestions for combination with angiogenesis inhibitorsC Damiano Gadaleta, Girolamo Ranieri
International Journal of Molecular Sciences|July 25, 2014
Possible prognostic and therapeutic significance of c-Kit expression, mast cell count and microvessel density in renal cell carcinomaIlaria Marech, Cosmo Damiano Gadaleta, Girolamo Ranieri
Biochimica Et Biophysica Acta|September 26, 2013
Aquaporins in cancerDomenico Ribatti, Girolamo Ranieri, Tiziana Annese, et al.
Critical Reviews in Oncology/Hematology|March 11, 2011
Yttrium-90 (90Y) in the principal radionuclide therapies: an efficacy correlation between peptide receptor radionuclide therapy, radioimmunotherapy and transarterial radioembolization therapy. Ten years of experience (1999-2009)Veronica Goffredo, Angelo Paradiso, Girolamo Ranieri, et al.
Recent Patents on Anti-Cancer Drug Discovery|January 29, 2008
Thymidine phosphorylase (platelet-derived endothelial cell growth factor) as a target for capecitabine: from biology to the bedsideGirolamo Ranieri, Aldo Maria Roccaro, Angelo Vacca, et al.
Neoplasia (New York, N.Y.)|March 13, 2013
The role of angiogenesis in human non-Hodgkin lymphomasDomenico Ribatti, Beatrice Nico, Girolamo Ranieri, et al.
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Current Medicinal Chemistry|January 5, 2012
Hot topic: targeting tumor angiogenesis: an updateGirolamo Ranieri
International Journal of Molecular Sciences|June 6, 2018
Biological Basis of Tumor Angiogenesis and Therapeutic Intervention: Past, Present, and FutureGirolamo Ranieri
Experimental Cell Research|December 6, 2014
Tryptase, a novel angiogenic factor stored in mast cell granulesDomenico Ribatti, Girolamo Ranieri
Cancers|September 29, 2020
Loco-Regional and Systemic Chemotherapies for Hepato-Pancreatic Tumors: Integrated TreatmentsGirolamo Ranieri, Carmelo Laface
Critical Reviews in Oncology/Hematology|November 12, 2010
Trans-arterial chemoembolization as a therapy for liver tumours: New clinical developments and suggestions for combination with angiogenesis inhibitorsC Damiano Gadaleta, Girolamo Ranieri
International Journal of Molecular Sciences|July 25, 2014
Possible prognostic and therapeutic significance of c-Kit expression, mast cell count and microvessel density in renal cell carcinomaIlaria Marech, Cosmo Damiano Gadaleta, Girolamo Ranieri
Biochimica Et Biophysica Acta|September 26, 2013
Aquaporins in cancerDomenico Ribatti, Girolamo Ranieri, Tiziana Annese, et al.
Critical Reviews in Oncology/Hematology|March 11, 2011
Yttrium-90 (90Y) in the principal radionuclide therapies: an efficacy correlation between peptide receptor radionuclide therapy, radioimmunotherapy and transarterial radioembolization therapy. Ten years of experience (1999-2009)Veronica Goffredo, Angelo Paradiso, Girolamo Ranieri, et al.
Recent Patents on Anti-Cancer Drug Discovery|January 29, 2008
Thymidine phosphorylase (platelet-derived endothelial cell growth factor) as a target for capecitabine: from biology to the bedsideGirolamo Ranieri, Aldo Maria Roccaro, Angelo Vacca, et al.
Neoplasia (New York, N.Y.)|March 13, 2013
The role of angiogenesis in human non-Hodgkin lymphomasDomenico Ribatti, Beatrice Nico, Girolamo Ranieri, et al.
Pageof 12